GatherJob
Back to jobs
R

Senior Specialist, IT Support, Europe

Revolution Medicines
SchweizOn-siteoperations Today

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) …

Adzuna

This is a preview — the full job description is on Adzuna.

Opens the company's application page

About the company

Revolution Medicines

Listed via

A

Adzuna

adzuna.com